Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y 12 inhibitor has been the standard of care to prevent thrombotic events in patients with acute coronary syndrome (ACS) undergoing ...
Patients with left main coronary artery disease who present with ACS fare just as well when treated with PCI as they do with CABG surgery, according to results of a new study. While ACS patients had ...
Patients with acute coronary syndromes complicated by cardiogenic shock (ACS-CS) who undergo PCI fare similarly regardless of whether their treating hospital does or doesn’t have cardiac surgical ...
The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer-reviewed. Various P2Y 12 inhibitors have different efficacies and bleeding risks, and ...
Please provide your email address to receive an email when new articles are posted on . “PCI is the preferred reperfusion strategy in patients presenting with ACS with latest-generation DES ...
Please provide your email address to receive an email when new articles are posted on . Although researchers could not associate pollen exposure with incident ACS, they did observe elevated ...
"This study suggests that the ARC-HBR and PRECISE-DAPT bleeding criteria can be used to risk stratify patients and guide the therapeutic selection to lower the bleeding risk. For instance, we found ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window This was a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results